[1]
“Influence of the clinical profile of patients with refractory epilepsy on lamotrigine plasma concentration”, Braz. J. Pharm. Sci., vol. 54, no. 2, p. e00246, Jul. 2018, doi: 10.1590/s2175-97902018000200246.